Novel thermo-sensitive core-shell nanoparticles for targeted paclitaxel delivery

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery

Background:

• Developing effective drug delivery systems for localized hyperthermia is crucial for cancer treatment.
• Thermo-sensitive nanoparticles can improve drug targeting and efficacy under specific temperature conditions.

Purpose of the Study:

• To design and characterize novel thermo-sensitive nanoparticles for targeted paclitaxel (PTX) delivery in hyperthermia.
• To evaluate the in vitro performance and anti-tumor activity of these PTX-loaded nanoparticles.

Main Methods:

• Self-assembly of poly(N,N-diethylacrylamide-co-acrylamide)-block-poly(gamma-benzyl L-glutamate) nanoparticles.
• Characterization using NMR, CD, fluorescence spectroscopy, DLS, and AFM.
• In vitro cytotoxicity assays on Hela cells with and without hyperthermia.

Main Results:

• Nanoparticles exhibited tunable lower critical solution temperature (LCST) between 37°C and 43°C.
• Paclitaxel encapsulation slightly increased nanoparticle size but maintained stability in BSA solution.
• Demonstrated thermo-sensitive PTX release and enhanced cytotoxicity under hyperthermia conditions.

Conclusions:

• The synthesized nanoparticles are promising candidates for thermal-triggered anti-tumor drug delivery.
• This system offers a potential strategy for localized hyperthermia-enhanced cancer therapy.
• Further research could optimize nanoparticle design for improved clinical outcomes.